Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

199
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
199
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

180
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
180
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

238
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
238
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

602
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
602
Aging01:26

Aging

139
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
139
Cognitive Therapy01:25

Cognitive Therapy

203
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
203

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Performance Ink-Writable Polyurethane Elastomers Based on Crystalline PCL and Hindered Urea Bonds.

Macromolecular rapid communications·2026
Same author

Integrin beta 4 promotes colorectal cancer progression by upregulating Ezrin and activating the Wnt/β‑catenin signaling pathway.

International journal of oncology·2026
Same author

Sustainable biotransformation of acanthopanax senticosus to isofraxidin using deep eutectic solvents: decoding metabolic crosstalk through transcriptomic and metabolomic Integration.

Preparative biochemistry & biotechnology·2026
Same author

Distinct supraspinal neural pathways underlie licking-induced alleviation of pain sensation and aversion in male mice.

Cell reports·2026
Same author

Metabolic reprogramming in endometriosis: mechanisms and therapeutic prospects.

Journal of advanced research·2026
Same author

Thymic stromal lymphopoietin promotes abdominal aortic aneurysm formation by regulating macrophage polarization.

Frontiers in immunology·2026

Related Experiment Video

Updated: Aug 16, 2025

Orienteering as a Tool for Cognitive Research: An Implementation Guide
07:13

Orienteering as a Tool for Cognitive Research: An Implementation Guide

Published on: November 29, 2024

866

Therapeutic approaches for improving cognitive function in the aging brain.

Lingmin Chen1, Jiao Jiao1, Yonggang Zhang2

  • 1Department of Anesthesiology and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University and The Research Units of West China (2018RU012), Chinese Academy of Medical Sciences, Chengdu, China.

Frontiers in Neuroscience
|December 26, 2022
PubMed
Summary

As global populations age, cognitive impairment becomes a significant concern. This review examines pharmacological and non-pharmacological strategies for enhancing or preserving cognitive function in older adults.

Keywords:
Alzheimer’s diseaseagingdementiainterventionmild cognitive impairmentnon-pharmacologicalpharmacological

More Related Videos

Transcranial Direct Current Stimulation tDCS for Memory Enhancement
10:37

Transcranial Direct Current Stimulation tDCS for Memory Enhancement

Published on: September 18, 2021

14.3K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.4K

Related Experiment Videos

Last Updated: Aug 16, 2025

Orienteering as a Tool for Cognitive Research: An Implementation Guide
07:13

Orienteering as a Tool for Cognitive Research: An Implementation Guide

Published on: November 29, 2024

866
Transcranial Direct Current Stimulation tDCS for Memory Enhancement
10:37

Transcranial Direct Current Stimulation tDCS for Memory Enhancement

Published on: September 18, 2021

14.3K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.4K

Area of Science:

  • Gerontology
  • Neuroscience
  • Pharmacology

Background:

  • Global population aging presents a significant challenge, increasing the prevalence of cognitive impairment, including dementia.
  • Maintaining cognitive function in the elderly is crucial for quality of life and public health.
  • Current pharmacological treatments for Alzheimer's disease are limited, necessitating exploration of new interventions.

Purpose of the Study:

  • To review recent evidence on pharmacological interventions for age-related cognitive decline.
  • To summarize non-pharmacological strategies for improving or maintaining cognition in the elderly.
  • To provide an overview of current and emerging treatments for cognitive impairment in aging populations.

Main Methods:

  • Systematic review of recent scientific literature.
  • Analysis of studies on drug development for cognitive enhancement.
  • Evaluation of evidence for non-pharmacological cognitive interventions.

Main Results:

  • Several pharmacological agents targeting age-related cognitive impairment are under development.
  • Non-pharmacological interventions such as cognitive training, brain stimulation, exercise, and lifestyle changes show promise.
  • A combination of approaches may be most effective for managing cognitive decline.

Conclusions:

  • Both pharmacological and non-pharmacological interventions are vital for addressing age-related cognitive impairment.
  • Further research is needed to establish the efficacy and safety of novel cognitive enhancers.
  • A multi-faceted approach is recommended for supporting cognitive health in aging individuals.